MicroRNA-221-3p alleviates cell apoptosis and inflammatory response by targeting cyclin dependent kinase inhibitor 1B in chronic obstructive pulmonary disease

References

• Curtis DJ, Smale A, Thien F, et al. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995 Jul;16(1):169–173.
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Gebke KB. Examining the role of activity, exercise, and pharmacology in mild COPD. Postgrad Med. 2014 Sep;126(5):135–145.
   PubMed Web of Science ®Google Scholar
• Spero K, Bayasi G, Beaudry L, et al. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2417–2423.
   PubMed Web of Science ®Google Scholar
• Brandsma CA, Van den Berge M, Hackett TL, et al. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol. 2020 Apr;250(5):624–635.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435–459.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Burney PG, Silverman EK, et al. Chronic obstructive pulmonary disease. Nat Rev Dis Primers. 2015 Dec;3(1):15076.
   Google Scholar
• Duffy SP, Criner GJ. Chronic obstructive pulmonary disease: evaluation and management. Med Clin North Am. 2019 May;103(3):453–461.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Abajobir AA, Abate KH. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017 Sep;5(9):691–706.
   PubMed Web of Science ®Google Scholar
• Garvey C, Bayles MP, Hamm LF, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016 Mar-Apr;36(2):75–83.
   PubMed Web of Science ®Google Scholar
• Ito JT, Lourenço JD, Righetti RF, et al. Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies? Cells. 2019 Apr 11;8(4). DOI:10.3390/cells8040342.
   Web of Science ®Google Scholar
• Milara J, Peiró T, Serrano A, et al. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax. 2013 May;68(5):410–420.
   PubMed Web of Science ®Google Scholar
• García-Sancha N, Corchado-Cobos R, Pérez-Losada J, et al. MicroRNA dysregulation in cutaneous squamous cell carcinoma. Int J Mol Sci. 2019 May 2;20(9). DOI:10.3390/ijms20092181.
   PubMed Web of Science ®Google Scholar
• Giudice A, Montella M, Boccellino M, et al. Epigenetic changes induced by green tea catechins a re associated with prostate cancer. Curr Mol Med. 2017;17(6):405–420.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu S, Shi J, et al. The role of miRNA in the diagnosis, prognosis, and treatment of osteosarcoma. Cancer Biother Radiopharm. 2019 Dec;34(10):605–613.
   PubMed Web of Science ®Google Scholar
• Jia Q, Chang J, Hong Q, et al. MiR-212-5p exerts a protective effect in chronic obstructive pulmonary disease. Discov Med. 2018 Nov;26(144):173–183.
   PubMed Web of Science ®Google Scholar
• He H, Wang H, Pei F, et al. MiR-543 regulates the development of chronic obstructive pulmonary disease by targeting interleukin-33. Clin Lab. 2018 Jul 1;64(7):1199–1205.
   PubMed Web of Science ®Google Scholar
• Gao HX, Su Y, Zhang AL, et al. MiR-34c-5p plays a protective role in chronic obstructive pulmonary disease via targeting CCL22. Exp Lung Res. 2019 Feb-Mar;45(1–2):1–12.
   PubMed Web of Science ®Google Scholar
• Feng J, Wang M, Li M, et al. Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients. Brain Res. 2019 Oct 1;1720:146296.
   PubMed Web of Science ®Google Scholar
• Zhang K, Liang Y, Feng Y, et al. Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma. Am J Physiol Lung Cell Mol Physiol. 2018 Aug 1;315(2):L253–l264.
   PubMed Web of Science ®Google Scholar
• Zhao L, Yuan Y, Li P, et al. miR-221-3p inhibits schwann cell myelination. Neuroscience. 2018 May 21;379:239–245.
   PubMed Web of Science ®Google Scholar
• Zhou CF, Ma J, Huang L, et al. Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 2019 Feb;38(8):1256–1268.
   PubMed Web of Science ®Google Scholar
• Joshi SR, Dhagia V, Gairhe S, et al. MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H689–98.
   PubMed Web of Science ®Google Scholar
• Nie X, Chen Y, Tan J, et al. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension. Vascul Pharmacol. 2019 May;116:24–35.
   PubMed Web of Science ®Google Scholar
• Yin G, Zhang B, Li J. miR‑221‑3p promotes the cell growth of non‑small cell lung cancer by targeting p27. Mol Med Rep. 2019 Jul;20(1):604–612.
   PubMed Web of Science ®Google Scholar
• Yu H, Xu L, Liu Z, et al. Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 are involved in the functions of XAV939 in non-small cell lung cancer. Can Respir J. 2019;2019:9107806.
   PubMed Web of Science ®Google Scholar
• Zhou X, Wen W, Shan X, et al. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis. Oncotarget. 2017 Jan 24;8(4):6513–6525.
   PubMedGoogle Scholar
• Hu L, Ye H, Liao J. LncRNA TUG1 reverses LPS-induced cell apoptosis and inflammation of macrophage via targeting MiR-221-3p/SPRED2 axis. Biosci Biotechnol Biochem. 2020 Aug;25:1–8.
   Google Scholar
• Conickx G, Mestdagh P, Avila Cobos F, et al. MicroRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017 Jan 1;195(1):43–56.
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009 Jan;19(1):92–105.
   PubMed Web of Science ®Google Scholar
• Quann K, Jing Y, Rigoutsos I. Post-transcriptional regulation of BRCA1 through its coding sequence by the miR-15/107 group of miRNAs. Front Genet. 2015;6:242.
   PubMed Web of Science ®Google Scholar
• Wang C, Lin Y, Fu Y, et al. MiR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3. Pflugers Arch. 2020 Nov;472(11):1607–1618.
   PubMed Web of Science ®Google Scholar
• He S, Zhang W, Li X, et al. Oral squamous cell carcinoma (OSCC)-derived exosomal MiR-221 targets and regulates phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) to promote human umbilical vein endothelial cells migration and tube formation. Bioengineered. 2021 Dec;12(1):2164–2174.
   PubMed Web of Science ®Google Scholar
• Araya J, Tsubouchi K, Sato N, et al. PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. Autophagy. 2019 Mar;15(3):510–526.
   PubMed Web of Science ®Google Scholar
• Chen X, Li Y, Hua C, et al. Establishment of rapid risk assessment model for cigarette smoke extract exposure in chronic obstructive pulmonary disease. Toxicol Lett. 2019 Nov;316:10–19.
   PubMed Web of Science ®Google Scholar
• Vij N, Chandramani-Shivalingappa P, Van Westphal C, et al. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis. Am J Physiol Cell Physiol. 2018 Jan 1;314(1):C73–c87.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 Dec;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Cao Y, Liu Y, Ping F, et al. miR-200b/c attenuates lipopolysaccharide-induced early pulmonary fibrosis by targeting ZEB1/2 via p38 MAPK and TGF-β/smad3 signaling pathways. Lab Invest. 2018 Mar;98(3):339–359.
   PubMed Web of Science ®Google Scholar
• Shetty SK, Tiwari N, Marudamuthu AS, et al. p53 and miR-34a feedback promotes lung epithelial injury and pulmonary fibrosis. Am J Pathol. 2017 May;187(5):1016–1034.
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhao FC, Pang Y, et al. Downregulation of miR-221-3p contributes to IL-1β-induced cartilage degradation by directly targeting the SDF1/CXCR4 signaling pathway. J Mol Med (Berl). 2017 Jun;95(6):615–627.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li H, Ma Y, et al. MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2. Biomed Pharmacother. 2019 Jan;109:127–134.
   PubMed Web of Science ®Google Scholar
• Shen Y, Lu H, Song G. MiR-221-3p and miR-92a-3p enhances smoking-induced inflammation in COPD. J Clin Lab Anal. 2021 Jul;35(7):e23857.
   PubMed Web of Science ®Google Scholar
• Zhao J, Cui L, Sun J, et al. Notoginsenoside R1 alleviates oxidized low-density lipoprotein-induced apoptosis, inflammatory response, and oxidative stress in HUVECS through modulation of XIST/miR-221-3p/TRAF6 axis. Cell Signal. 2020 Sep 15;76:109781.
   PubMed Web of Science ®Google Scholar
• Zhu L, Gong X, Gong J, et al. Notoginsenoside R1 upregulates miR-221-3p expression to alleviate ox-LDL-induced apoptosis, inflammation, and oxidative stress by inhibiting the TLR4/NF-κB pathway in HUVECs. Braz J Med Biol Res. 2020;53(6):e9346.
   PubMed Web of Science ®Google Scholar
• Rong J, Xu J, Liu Q, et al. Anti-inflammatory effect of up-regulated microRNA-221-3p on coronary heart disease via suppressing NLRP3/ASC/pro-caspase-1 inflammasome pathway activation. Cell Cycle. 2020 Jun;19(12):1478–1491.
   PubMed Web of Science ®Google Scholar
• Scully KM, Lahmy R, Signaevskaia L, et al. E47 governs the MYC-CDKN1B/p27(KIP1)-RB network to growth arrest PDA cells independent of CDKN2A/p16(INK4A) and wild-type p53. Cell Mol Gastroenterol Hepatol. 2018;6(2):181–198.
   PubMed Web of Science ®Google Scholar
• Whitcomb EA, Tsai YC, Basappa J, et al. Stabilization of p27(Kip1)/CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control. Faseb J. 2019 Jan;33(1):1235–1247.
   PubMed Web of Science ®Google Scholar
• Wu DM, Wen X, Han XR, et al. MiR-142-3p enhances cell viability and inhibits apoptosis by targeting CDKN1B and TIMP3 following sciatic nerve injury. Cell Physiol Biochem. 2018;46(6):2347–2357.
   PubMedGoogle Scholar
• Chen D, Wang X, Huang J, et al. CDKN1B mediates apoptosis of neuronal cells and inflammation induced by oxyhemoglobin via miR-502-5p after subarachnoid hemorrhage. J Mol Neurosci. 2020 Jul;70(7):1073–1080.
   PubMed Web of Science ®Google Scholar